National Institute of Nursing Research (NINR)
A. Technologies to be used in the hospital, long-term care, hospice, assisted living facility, or home setting that improve symptom diagnosis, evaluation and management in persons with chronic conditions.
B. Devices that improve the acceptance and use of assistive and monitoring devices.
C. Devices to diagnose and screen for COPD early in the course of the disease, particularly targeting young adults.
D. Technologies to assist in health promotion and prevention activities across the lifespan.
E. Devices to assist in providing palliative care for patients with life threatening illnesses through the disease trajectory whether in active treatment or at the end of life.
F. Technologies to assist individuals in reducing environmental exposures, i.e., chemical, bacterial and viral agents, and indoor/outdoor allergens.
G. Devices to facilitate resource sharing such as: technologies that will enable valid and reliable measurement tools/instruments to be readily available and shared by research scientists focused on similar issues in a variety of populations.
H. Adaptation of existing or development of new technologies that will link under-represented and/or underserved populations with available resources to sustain healthy life styles and eliminate health disparities.
I. Devices to measure and monitor effect of physical activity on symptom improvement.
Research and Development of Technologies to Enhance Self Care and Clinical Care
A. Technologies to assist patients to adhere to chronic regimens such as reminding children to take steroid inhalers during the day for asthma; alerting obese adults when high calorie and fat content foods are about to be eaten; adhering to medication regimens; and prompting sedentary adults to exercise.
B. Devices that improve delivery of care to persons who have restricted or impaired movement due to (1) conditions of neurological disease or injury, peripheral vascular disease, rheumatoid disease, or intractable pain, (2) life sustaining equipment, such as dialysis machines or left ventricular assist devices, or (3) orthopedic fixation devices.
C. Devices to enable providers and or research scientists to monitor successful adherence to complex medication regimens (e.g., Highly Active Anti-Retroviral treatment).
D. Technologies that monitor short and long term self-care behavior changes.
E. Biological and behavioral monitoring devices for patients in at-risk and underserved populations in rural and frontier areas that will enable access to clinical care.
F. Telehealth and mHealth technologies to improve patient outcomes through increasing quality, type, and speed of health information sharing, e.g., assessing traumatic injury severity at remote sites and transmitting this information to acute care settings for assessment and evaluation; communicating signs and symptoms of clients at home to health care providers in distant locations; tailoring care for diverse patients in a wide variety of settings, and promoting community interventions to eliminate health disparities.
G. Technologies to treat chronic wounds that fail to heal, specifically decubitus ulcers, venous stasis ulcers, and diabetic ulcers.
H. Technologies to be used in the hospital or home care setting to monitor or assess preterm, low-birth weight or other high-risk infants.
I. Technologies to assist informal caregivers in providing care or assistance to family members in the home.
J. Noninvasive devices to assess exposure to chemical, bacterial and viral agents for children and adults and transmit this information to health care personnel for assessment and evaluation.
K. Technologies to disseminate research information (i.e., biobehavioral responses, communication of risk, bioethics) to nurses practicing in emergency settings and in the community.
L. Technologies and informatics-based solutions that promote health, including comprehensive high-throughput technologies.
M. Develop and creatively apply new and existing knowledge to the implementation of health information technology, including electronic health records.
N. Health care technologies to facilitate decision support, self-management, and access to health care.
O. Utilization of genetic and genomic technologies to advance knowledge of the ?symptome? including the biological underpinnings of symptoms associated with chronic illness.
Other Research Topic(s) Within the Mission of the Institute
A. Micro- and Nano-Systems, Platform Technologies. Development of BioMEMS, microfluidics and nanoscale technologies, including micro-total analysis systems, arrays, and biochips, for detection and quantitation of clinically relevant analytes in complex matrices. Application areas include biomedical research, clinical laboratory diagnostics, biodefense, high-throughput screening, drug delivery, tissue engineering, and implantable devices, among others.
B. Nanotechnology. Research and development of new enabling technologies for the fabrication and use of nanoscale components and systems in diagnostic and therapeutic applications. Examples include: development of new nanoscale patterning and manipulation systems; new approaches to the sensing and quantification of biologically important molecules using nanoscale specific properties; studies relating to the safety and commercialization of nanotechnology-enabled biomedical products.
- Agency: Department of Health and Human Services,Department of Health and Human Services
- Program: STTR
- Phase: Phase I
- Release Date: August 05, 2015
- Open Date: August 05, 2015
- Close Date: April 05, 2016
- URL: https://grants.nih.gov/grants/guide/pa-files/PA-15-270.html